NCT01455584View on ClinicalTrials.gov

Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Advanced Solid Malignancies
Interventions
DRUG

HM781-36B tablets

Q1X28D/4W for HM781-36B tablets

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01455584 - Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter